The diagnostic test results are a crucial aspect in the treatment decisions. Timely and reliable diagnosis ensures the correct analysis and treatment schedule in addition to reducing the overall treatment costs
Read MoreThe erstwhile promoters of Ranbaxy Laboratories, the Singh brothers and family have been asked to pay damages of Rs 2,562.78 crore to Daiichi by an arbitration tribunal in Singapore for concealing and misrepresenting information during their stake sell to the Japanese firm
Read MorePfizer's approach comes less than a week after Sanofi went public with its $52.50 per share cash offer, complaining that Medivation refused to engage.
Read MoreWith the rise of branded private hospitals across the country, the ‘healthcare consumer’ today can no more be treated as a patient alone.
Read MoreThe company, which is planning a pan India presence by setting up its teams in almost all cities in the next 4 to 5 years, would also double its staff strength to some 1,200 by 2020
Read MoreThis situation is unique to India, where sales growth of companies is closely connected to brand launches
Read MoreCorporates represent a market of 50 million employees and this segment is ready for evolved employee health benefits, says Varun Gera of HealthAssure
Read MoreSri Krishna Pharmaceuticals, a supplier of paracetamol and other drugs to more than 60 countries, has been warned by the US Food and Drug Administration, which cited manipulation of its test results at a plant
Read More